Jupiter Neurosciences (JUNS) Revenue & Revenue Breakdown
Jupiter Neurosciences Revenue Highlights
0
Latest Revenue (Q)
$18.65K
Jupiter Neurosciences Revenue by Period
Jupiter Neurosciences Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2025-12-31 | - | 100.00% |
| 2024-12-31 | - | 100.00% |
| 2023-12-31 | - | -100.00% |
| 2022-12-31 | $233.28K | -63.44% |
| 2021-12-31 | $638.04K | -43.35% |
| 2020-12-31 | $1.13M | 100.00% |
| 2019-12-31 | - | - |
Jupiter Neurosciences generated - in revenue during NA 2025, up 100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.
Jupiter Neurosciences Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2026-03-31 | $18.65K | -14.42% |
| 2025-12-31 | $21.80K | 100.00% |
| 2025-09-30 | - | 100.00% |
| 2025-06-30 | - | 100.00% |
| 2025-03-31 | - | 100.00% |
| 2024-12-31 | - | 100.00% |
| 2024-09-30 | - | 100.00% |
| 2024-06-30 | - | 100.00% |
| 2024-03-31 | - | 100.00% |
| 2023-12-31 | - | 100.00% |
| 2023-09-30 | - | 100.00% |
| 2023-06-30 | - | 100.00% |
| 2023-03-31 | - | -100.00% |
| 2022-06-30 | $233.28K | 100.00% |
| 2022-03-31 | - | 100.00% |
| 2021-12-31 | - | 100.00% |
| 2021-09-30 | - | -100.00% |
| 2021-06-30 | $264.27K | -29.30% |
| 2021-03-31 | $373.77K | -63.54% |
| 2020-12-31 | $1.03M | 100.00% |
| 2020-09-30 | - | - |
Jupiter Neurosciences generated $18.65K in revenue during Q1 2026, up -14.42% compared to the previous quarter, and up Infinity% compared to the same period a year ago.
Jupiter Neurosciences Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| MRSN | Mersana Therapeutics | $40.50M | $11.01M |
| XFOR | X4 Pharmaceuticals | $35.11M | $1.76M |
| FGEN | FibroGen | $6.44M | $3.74M |
| ABVC | ABVC BioPharma | $795.95K | - |
| JUNS | Jupiter Neurosciences | - | $18.65K |
| KZR | Kezar Life Sciences | - | - |
| ALGS | Aligos Therapeutics | - | - |
| GNTA | Genenta Science S.p.A. | - | - |
| SKYE | Skye Bioscience | - | - |
| GRCE | Grace Therapeutics | - | - |